Q9Y2K6 (UBP20_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 119.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ubiquitin carboxyl-terminal hydrolase 20 EC=3.4.19.12 Alternative name(s): Deubiquitinating enzyme 20 Ubiquitin thioesterase 20 Ubiquitin-specific-processing protease 20 VHL-interacting deubiquitinating enzyme 2 Short name=hVDU2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 914 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Deubiquitinating enzyme involved in beta-2 adrenergic receptor (ADRB2) recycling. Acts as a regulator of G-protein coupled receptor (GPCR) signaling by mediating the deubiquitination beta-2 adrenergic receptor (ADRB2). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta-arrestins, possibly leading to beta-arrestins deubiquitination and disengagement from ADRB2. This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Deubiquitinates HIF1A, leading to stabilize HIF1A and enhance HIF1A-mediated activity. Mediates deubiquitination of both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. Ref.1 Ref.7 Ref.8 Ref.12 |
| Catalytic activity | Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). |
| Subunit structure | Interacts with VHL, leading to its ubiquitination and subsequent degradation. Interacts with DIO2 and HIF1A. Ref.1 Ref.7 Ref.8 Ref.12 |
| Subcellular location | Cytoplasm › perinuclear region By similarity. Note: According to Ref.7, it localizes in the endoplasmic reticulum; however the relevance of such result is unclear. |
| Domain | The UBP-type zinc finger binds 3 zinc ions. However, it does not bind ubiquitin, probably because the conserved Arg in position 55 is replaced by a Glu residue By similarity. |
| Post-translational modification | Ubiquitinated via a VHL-dependent pathway for proteasomal degradation. Ref.1 |
| Sequence similarities | Belongs to the peptidase C19 family. USP20/USP33 subfamily. Contains 2 DUSP domains. Contains 1 UBP-type zinc finger. |
| Sequence caution | The sequence BAA76847.2 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 914 | 914 | Ubiquitin carboxyl-terminal hydrolase 20 | PRO_0000080647 | |||||
Regions | |||||||||
| Domain | 687 – 780 | 94 | DUSP 1 | ||||||
| Domain | 789 – 892 | 104 | DUSP 2 | ||||||
| Zinc finger | 28 – 92 | 65 | UBP-type | ||||||
Sites | |||||||||
| Active site | 154 | 1 | Nucleophile | ||||||
| Active site | 643 | 1 | Proton acceptor By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 132 | 1 | Phosphoserine Ref.10 Ref.13 | ||||||
| Modified residue | 134 | 1 | Phosphoserine Ref.10 Ref.13 | ||||||
| Modified residue | 258 | 1 | Phosphothreonine Ref.9 | ||||||
| Modified residue | 377 | 1 | Phosphothreonine Ref.11 | ||||||
| Modified residue | 413 | 1 | Phosphoserine Ref.11 | ||||||
Natural variations | |||||||||
| Natural variant | 103 | 1 | S → Y. Corresponds to variant rs36086252 [ dbSNP | Ensembl ]. | VAR_051529 | |||||
| Natural variant | 444 | 1 | V → I. Corresponds to variant rs36055332 [ dbSNP | Ensembl ]. | VAR_051530 | |||||
Experimental info | |||||||||
| Mutagenesis | 154 | 1 | C → S: Abolishes deubiquitinating activity. Does not inhibit lysosomal trafficking of ADRB2; when associated with Q-643. Ref.12 | ||||||
| Mutagenesis | 643 | 1 | H → Q: Abolishes deubiquitinating activity. Does not inhibit lysosomal trafficking of ADRB2; when associated with S-154. Ref.12 | ||||||
| Sequence conflict | 320 | 1 | A → V in AAL79676. Ref.1 | ||||||
| Sequence conflict | 320 | 1 | A → V in BAA76847. Ref.2 | ||||||
| Sequence conflict | 359 | 1 | Missing in AAL79676. Ref.1 | ||||||
| Sequence conflict | 359 | 1 | Missing in BAA76847. Ref.2 | ||||||
| Sequence conflict | 359 | 1 | Missing in EAW87914. Ref.4 | ||||||
| Sequence conflict | 359 | 1 | Missing in AAH39593. Ref.5 | ||||||
| Sequence conflict | 776 | 1 | H → Q in CAB44350. Ref.6 | ||||||
| Sequence conflict | 794 | 1 | R → M in CAB44350. Ref.6 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor." Li Z., Wang D., Na X., Schoen S.R., Messing E.M., Wu G. Biochem. Biophys. Res. Commun. 294:700-709(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, UBIQUITINATION, INTERACTION WITH VHL. |
| [2] | "Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 6:63-70(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [3] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Ovary. |
| [6] | "Extensive gene order differences within regions of conserved synteny between the Fugu and human genomes: implications for chromosomal evolution and the cloning of disease genes." Gilley J., Fried M. Hum. Mol. Genet. 8:1313-1320(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 581-803 AND 839-914. |
| [7] | "Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation." Curcio-Morelli C., Zavacki A.M., Christofollete M., Gereben B., de Freitas B.C., Harney J.W., Li Z., Wu G., Bianco A.C. J. Clin. Invest. 112:189-196(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH DIO2. |
| [8] | "VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha." Li Z., Wang D., Messing E.M., Wu G. EMBO Rep. 6:373-378(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH HIF1A. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-258, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-134, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-377 AND SER-413, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization." Berthouze M., Venkataramanan V., Li Y., Shenoy S.K. EMBO J. 28:1684-1696(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH ADRB2, MUTAGENESIS OF CYS-154 AND HIS-643. |
| [13] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-134, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AY074877 mRNA. Translation: AAL79676.1. AB023220 mRNA. Translation: BAA76847.2. Different initiation. AL158207 Genomic DNA. Translation: CAC88170.1. CH471090 Genomic DNA. Translation: EAW87914.1. BC039593 mRNA. Translation: AAH39593.1. Y17457 Genomic DNA. Translation: CAB44350.1. Y17459 Genomic DNA. Translation: CAB44352.1. |
| IPI | IPI00328285. |
| RefSeq | NP_001008563.2. NM_001008563.4. NP_001103773.2. NM_001110303.3. NP_006667.3. NM_006676.7. |
| UniGene | Hs.5452. |
3D structure databases | |
| ProteinModelPortal | Q9Y2K6. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9Y2K6. 40 interactions. |
| STRING | 9606.ENSP00000313811. |
Protein family/group databases | |
| MEROPS | C19.025. |
PTM databases | |
| PhosphoSite | Q9Y2K6. |
Polymorphism databases | |
| DMDM | 116242837. |
Proteomic databases | |
| PaxDb | Q9Y2K6. |
| PRIDE | Q9Y2K6. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000315480; ENSP00000313811; ENSG00000136878. ENST00000358355; ENSP00000351122; ENSG00000136878. ENST00000372429; ENSP00000361506; ENSG00000136878. |
| GeneID | 10868. |
| KEGG | hsa:10868. |
| UCSC | uc004byr.2. human. |
Organism-specific databases | |
| CTD | 10868. |
| GeneCards | GC09P132596. |
| H-InvDB | HIX0008459. |
| HGNC | HGNC:12619. USP20. |
| HPA | HPA006287. |
| neXtProt | NX_Q9Y2K6. |
| PharmGKB | PA37245. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG5560. |
| HOGENOM | HOG000286031. |
| HOVERGEN | HBG054196. |
| InParanoid | Q9Y2K6. |
| KO | K11848. |
| OMA | ADYGQIS. |
| OrthoDB | EOG4D52WZ. |
| PhylomeDB | Q9Y2K6. |
Gene expression databases | |
| ArrayExpress | Q9Y2K6. |
| Bgee | Q9Y2K6. |
| CleanEx | HS_USP20. |
| Genevestigator | Q9Y2K6. |
| GermOnline | ENSG00000136878. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.30.40.10. 1 hit. |
| InterPro | IPR006615. Pept_C19_DUSP. IPR018200. Pept_C19ubi-hydrolase_C_CS. IPR001394. Peptidase_C19. IPR013083. Znf_RING/FYVE/PHD. IPR001607. Znf_UBP. [Graphical view] |
| Pfam | PF06337. DUSP. 1 hit. PF00443. UCH. 1 hit. PF02148. zf-UBP. 1 hit. [Graphical view] |
| SMART | SM00695. DUSP. 2 hits. [Graphical view] |
| PROSITE | PS51283. DUSP. 2 hits. PS00972. UCH_2_1. 1 hit. PS00973. UCH_2_2. 1 hit. PS50235. UCH_2_3. 1 hit. PS50271. ZF_UBP. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | USP20. human. |
| GenomeRNAi | 10868. |
| NextBio | 41265. |
Entry information
| Entry name | UBP20_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y2K6 Secondary accession number(s): Q541F1 Q9UQP0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with
